Results 31 to 40 of about 20,498,806 (233)

Focal salvage high-dose-rate brachytherapy with implantable rectum spacer for locally recurrent prostate cancer after initial low-dose-rate with grade 3 rectal toxicity

open access: yes, 2023
Purpose: Locally recurrent prostate cancer after previous radiation therapy remains challenging. One of the cura-tive options for these patients is salvage brachytherapy.
Opbroek, Thirza   +7 more
core   +1 more source

Modern development of high-dose-rate brachytherapy [PDF]

open access: yesJapanese Journal of Clinical Oncology, 2020
AbstractBrachytherapy is an invasive therapy with placement of radiation source into or near the tumor. The difference between planning target volume and clinical target volume is minimal, and the dose out of the tumor reduces rapidly due to the inverse-square law.
openaire   +2 more sources

Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer [PDF]

open access: yes, 2016
Purpose : The aim of the study was to report our experience with high-dose-rate interstitial brachytherapy (HDR-ISBT) in locally advanced and recurrent vulvar cancer.
Ślęczka, Maciej   +15 more
core   +1 more source

High dose rate brachytherapy

open access: yesInternational Journal of Radiation Oncology*Biology*Physics, 1993
The high dose rate brachytherapy uses a single source os 192Ir with 10Ci of nominal activity in a remote afterloading machine. This technique allows an outpatient treatment, without the inconveniences of the conventional low dose rate brachytherapy such as use of general anesthesia, rhachianesthesia, prolonged immobilization, and personal exposition to
S, Aisen   +8 more
openaire   +3 more sources

Efficacy of focal high-dose-rate brachytherapy in the treatment of patients diagnosed with low or favourable intermediate-risk prostate cancer—a protocol for a randomised controlled trial

open access: yesBMJ Open, 2023
Introduction Prostate cancer (PCa) is men’s second most predominant cancer worldwide. Because the prostate-specific antigen test is used in diagnostics, PCa is more often diagnosed in the early stages, making radical treatment of the disease possible ...
Ausvydas Patasius   +6 more
doaj   +1 more source

Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma

open access: yesTumor Biology, 2017
Radioresistance often leads to poor survival in concurrent chemoradiotherapy–treated cervical squamous cell carcinoma, and reliable biomarkers can improve prognosis.
Oyeon Cho   +6 more
doaj   +1 more source

An audit of high dose-rate prostate brachytherapy treatment planning at six Swedish clinics

open access: yes, 2021
Purpose: High dose-rate prostate brachytherapy has been implemented in Sweden in the late 1980s and early 1990s in six clinics using the same schedule: 20 Gy in two fractions combined with 50 Gy in 25 fractions with external beam radiation therapy ...
Sakarias Johansson   +19 more
core   +1 more source

Urethral toxicity vs. cancer control-Lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer

open access: yes, 2011
To describe biochemical relapse-free survival (BRFS) and late toxicity after combined high-dose rate brachytherapy (HDR-B) and intensity-modulated radiation therapy (IMRT) in intermediate- and high-risk prostate cancer ...
Daniel M. Aebersold   +17 more
core   +2 more sources

High-dose-rate brachytherapy (interventional radiotherapy) in lip carcinoma with rigid needles: a simple technique with excellent results

open access: yesJournal of Contemporary Brachytherapy, 2022
Lip carcinoma has been treated for years with low-dose-rate (LDR) brachytherapy, achieving local control greater than 90%. Comparison between LDR and high-dose-rate (HDR) showed that they are equivalently efficient in local control, but HDR results in ...
Jose Luis Guinot   +4 more
doaj   +1 more source

High-dose-rate brachytherapy in the treatment of skin Kaposi sarcoma

open access: yes, 2017
Purpose : The aim of the study is to review our experience in treatment of Kaposi sarcoma (KS) lesions with high-dose-rate (HDR) brachytherapy. Material and methods : We present five new KS lesions (three patients) that were treated in our hospital ...
Joaquín José Cabrera Rodríguez   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy